BlossomHill Therapeutics (BLSM) vs Helus Pharma (HELP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Helus Pharma is the larger company by market cap ($487.7 million vs $461.2 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BLSM | HELP |
|---|---|---|
| Share price | $14.51 | $6.11 |
| Market cap | $461.20M | $487.68M |
| 1-day change | +0.69% | -9.88% |
| YTD return | — | -25.31% |
| 1-year return | — | +9.30% |
| 5-year return | — | -88.09% |
| EPS (TTM) | $-10.38 | $-4.25 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $27.99 | $15.15 |
| 52-week low | $11.02 | $3.76 |
| Distance from 52-week high | -48.16% | -59.67% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +143.97% | +564.81% |
| Average volume | 193.15K | 1.83M |
| Shares outstanding | 31.78M | 79.81M |
| Employees | 69 | 100 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About BlossomHill Therapeutics
BLSM stock →BlossomHill Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecule medicines that address medical needs in cancer treatment. Its pipeline includes BH-30643, an OMNI-EGFR inhibitor in clinical development for advanced EGFR-mutant non-small cell lung cancer (NSCLC), BH-501284, and BH-30236, a macrocyclic CLK (Cdc2-like kinase) inhibitor being evaluated in patients with relapsed or refractory acute myeloid leukemia (R/R AML) and higher-risk myelodysplastic syndrome (HR-MDS).
Health Care · Biotechnology: Pharmaceutical Preparations · 69 employees
About Helus Pharma
HELP stock →Helus Pharma Inc. operates as a clinical stage pharmaceutical company that focuses on developing therapies to treat psychiatric and neurological conditions.
Health Care · Biotechnology: Pharmaceutical Preparations · 100 employees
BLSM vs HELP FAQ
Which is bigger, BlossomHill Therapeutics or Helus Pharma?
Helus Pharma (HELP) is larger, with a market capitalization of $487.68M compared with $461.20M for BlossomHill Therapeutics (BLSM).
Are BlossomHill Therapeutics and Helus Pharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.